Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
Tweet Send to a Friend
(Updated - August 20, 2026 9:20 AM EDT)
Benchmark analyst Bruce Jackson raised the price target on Unicycive Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Bruce Jackson raised the price target on Unicycive Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
